143 related articles for article (PubMed ID: 1335763)
1. Establishment of a human T-cell line constitutively producing several eosinophil chemotactic lymphokines and their functional heterogeneity on eosinophils.
Hirashima M; Ueno M; Higuchi S; Matsumoto T; Sakata KM; Matsumoto R; Adachi M
Lymphokine Cytokine Res; 1992 Dec; 11(6):331-8. PubMed ID: 1335763
[TBL] [Abstract][Full Text] [Related]
2. Chemotactic heterogeneity of eosinophils in Kimura's disease.
Saita N; Ueno M; Yoshida M; Kimura T; Ando M; Hirashima M
Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):21-3. PubMed ID: 8155998
[TBL] [Abstract][Full Text] [Related]
3. Functional heterogeneity of human eosinophil chemotactic lymphokines.
Hirashima M; Ueno M; Kamiya K; Higuchi S; Matsumoto R
Lymphokine Cytokine Res; 1991 Dec; 10(6):481-6. PubMed ID: 1804311
[TBL] [Abstract][Full Text] [Related]
4. [Type IV allergic reaction (delayed type)].
Hirashima M
Nihon Rinsho; 1993 Mar; 51(3):669-74. PubMed ID: 8492441
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil chemotactic lymphokine produced by spleen cells of Schistosoma japonicum-infected mice. II. Physicochemical heterogeneity of eosinophil chemotactic lymphokines selective to bone marrow- or peritoneal exudate-eosinophils.
Owhashi M; Nawa Y
Int Arch Allergy Appl Immunol; 1987; 83(3):290-5. PubMed ID: 3110075
[TBL] [Abstract][Full Text] [Related]
6. Induction of an eosinophil chemotactic factor production from T lymphocytes by a B cell lymphoma line.
Hirashima M; Ueno M; Saita N; Takamura S; Watanabe K; Tsurufuji S; Adachi M
Immunol Lett; 1993 Jun; 36(3):273-81. PubMed ID: 8370599
[TBL] [Abstract][Full Text] [Related]
7. Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.
Goetzl EJ; Tashjian AH; Rubin RH; Austen KF
J Clin Invest; 1978 Mar; 61(3):770-80. PubMed ID: 641154
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil chemotactic lymphokine produced by spleen cells of Schistosoma japonicum-infected mice. III. Isolation and characterization of two distinctive eosinophil chemotactic lymphokines directed against different maturation stages of eosinophils.
Owhashi M; Nawa Y
Int Arch Allergy Appl Immunol; 1987; 84(2):185-9. PubMed ID: 3115903
[TBL] [Abstract][Full Text] [Related]
9. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
10. The regulation of tissue eosinophil chemotactic factor and inhibitor in allergic skin lesions of Freund's complete adjuvant-treated guinea-pigs.
Hirashima M; Tashiro K; Hayashi H
Immunology; 1984 Mar; 51(3):441-50. PubMed ID: 6365742
[TBL] [Abstract][Full Text] [Related]
11. Isolation of an eosinophil chemotactic lymphokine as a natural mediator for eosinophil chemotaxis from concanavalin A-induced skin reaction sites in guinea-pigs.
Hirashima M; Tashiro K; Sakata K; Hirashima M
Clin Exp Immunol; 1984 Jul; 57(1):211-9. PubMed ID: 6378462
[TBL] [Abstract][Full Text] [Related]
12. RANTES is a chemotactic and activating factor for human eosinophils.
Alam R; Stafford S; Forsythe P; Harrison R; Faubion D; Lett-Brown MA; Grant JA
J Immunol; 1993 Apr; 150(8 Pt 1):3442-8. PubMed ID: 7682241
[TBL] [Abstract][Full Text] [Related]
13. Expression of apoptosis-related antigen on eosinophils in chronic eosinophilic pneumonia.
Saita N; Yamanaka T; Kohrogi H; Matsumoto M; Suga M; Ando M; Hirashima M
Int Arch Allergy Immunol; 1997 Oct; 114 Suppl 1():64-6. PubMed ID: 9363929
[TBL] [Abstract][Full Text] [Related]
14. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
Goetzl EJ
Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
[TBL] [Abstract][Full Text] [Related]
15. Chemotactic cytokines and inflammation. Biological properties of the lymphocyte and monocyte chemotactic factors ELCF, MCAF and IL-8.
Zachariae CO
Acta Derm Venereol Suppl (Stockh); 1993; 181():1-37. PubMed ID: 7901957
[TBL] [Abstract][Full Text] [Related]
16. Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes.
Czarnetzki BM; König W; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1978; 56(5):398-408. PubMed ID: 344231
[TBL] [Abstract][Full Text] [Related]
17. T-cell-derived IgE-binding factors. II. Purification and characterization of IgE-binding factors produced by human T cell leukemia/lymphoma virus-1-transformed T lymphocytes.
Sarfati M; Nutman TB; Suter U; Hofstetter H; Delespesse G
J Immunol; 1987 Dec; 139(12):4055-60. PubMed ID: 2826578
[TBL] [Abstract][Full Text] [Related]
18. Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid.
König W; Tesch H; Frickhofen N
Eur J Immunol; 1978 Jun; 8(6):434-7. PubMed ID: 352712
[TBL] [Abstract][Full Text] [Related]
19. The regulation of tissue eosinophilia. III. In vitro production of eosinophil-directed chemotactic inhibitory factor by T lymphocytes of complete Freund's adjuvant-treated guinea-pigs.
Tashiro K; Sakata K; Hirashima M; Hayashi H
Immunology; 1985 May; 55(1):115-24. PubMed ID: 3873403
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil chemotactic factor. Release from human polymorphonuclear neutrophils by arachidonic acid.
Tesch H; König W; Frickhofen N
Int Arch Allergy Appl Immunol; 1979; 58(4):436-46. PubMed ID: 35469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
